A. Moran

Asthma management in the Asia–Pacific region

L. Beckert, A. Moran, 2014, Respirology.

Anti-IL-4/IL-13 for the treatment of asthma: the story so far

I. Pavord, A. Moran, 2020, Expert opinion on biological therapy.

COPD exacerbation phenotypes: The next frontier

I. Pavord, A. Moran, 2019, Respirology.

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

I. Pavord, T. Hinks, C. Borg, 2022, Thorax.

P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population

C. Brightling, M. Bafadhel, I. Pavord, 2019, Asthma: endotypes/biomarkers.

Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma

I. Pavord, T. Hinks, C. Borg, 2020, American journal of respiratory and critical care medicine.

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma

I. Pavord, T. Hinks, C. Borg, 2020, American journal of respiratory and critical care medicine.

Is higher population‐level use of ICS/LABA combination associated with better asthma outcomes? Cross‐sectional surveys of nationally representative populations in New Zealand and Australia

S. Sawyer, H. Reddel, R. Ampon, 2017, Respirology.